Skin toxicity after Filgrastim treatment for an Ewing's sarcoma patient.
Introduction: Filgrastim is a granulocyte colony-stimulating factor (GSCF) used in some chemotherapy regimen to prevent febrile neutropenia. Most common reaction of filgrastim are aches and pain including headaches, nausea and skin rash. Case report: We report the case of a patient who developed unu...
| Publicado en: | Journal of Oncology Pharmacy Practice Vol. 28; no. 4; pp. 995 - 998 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | case study pictorial Journal Article |
| Publicado: |
Sage Publications Inc.
Jun2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |